Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia
NCT00021749
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Lymphocytic Leukemia
CLL
Interventions
DRUG:
Oblimerson sodium, G3139
Sponsor
Genta Incorporated